Clinical Trials Browser

Phase 1 × Neuroblastoma × Bevacizumab × Clear all

NCT00885326 2023-04-10

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

Phase 1 Completed

Neuroblastoma

NCT00450827 2015-09-28

Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma

Phase 1 Completed

Neuroblastoma